Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:FRE NYSE:MED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFREFremont GoldC$0.15C$0.15C$0.05▼C$0.17C$8.71M0.4340,741 shs28,000 shsMEDMedifast$12.60+0.0%$10.93$9.22▼$15.46$140.10M0.55192,214 shs208,221 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFREFremont Gold0.00%0.00%0.00%0.00%0.00%MEDMedifast+0.37%+0.12%+14.45%+18.51%-4.96%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFREFremont GoldC$0.15C$0.15C$0.05▼C$0.17C$8.71M0.4340,741 shs28,000 shsMEDMedifast$12.60+0.0%$10.93$9.22▼$15.46$140.10M0.55192,214 shs208,221 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFREFremont Gold0.00%0.00%0.00%0.00%0.00%MEDMedifast+0.37%+0.12%+14.45%+18.51%-4.96%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFREFremont Gold 0.00N/AN/AN/AMEDMedifast 1.50Reduce$12.00-4.77% DownsideCurrent Analyst Ratings BreakdownLatest MED and FRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026MEDMedifast Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFREFremont GoldN/AN/AC$0.08 per share1.84C$0.01 per shareN/AMEDMedifast$385.79M0.36$0.42 per share30.36$17.78 per share0.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFREFremont Gold-C$6.24M-C$0.11N/AN/AN/AN/A-257.67%-104.83%N/AMEDMedifast-$18.67M-$1.83N/AN/AN/A-5.78%-4.80%-3.83%8/3/2026 (Estimated)Latest MED and FRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/4/2026Q1 2026MEDMedifast-$0.55-$0.19+$0.36-$0.19$69.20 million$76.04 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthFREFremont GoldN/A12.12%N/AN/AN/AMEDMedifastN/AN/A-100.00%N/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFREFremont GoldN/A0.891.79MEDMedifastN/A4.804.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFREFremont Gold0.69%MEDMedifast95.51%Insider OwnershipCompanyInsider OwnershipFREFremont Gold22.50%MEDMedifast3.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFREFremont GoldN/A58.07 millionN/ANot OptionableMEDMedifast87011.12 million10.71 millionOptionableMED and FRE HeadlinesRecent News About These CompaniesWeight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term OutcomesMay 21 at 7:00 AM | globenewswire.comThe Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to DoMay 21 at 7:00 AM | globenewswire.comMedifast (NYSE:MED) Stock Crosses Above Two Hundred Day Moving Average - What's Next?May 20 at 2:40 AM | americanbankingnews.comPeer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass PreservationMay 15, 2026 | globenewswire.comPeer-Reviewed Research Is Redefining Weight Loss Program StandardsMay 15, 2026 | globenewswire.comInsider Buying: Medifast (NYSE:MED) Director Acquires 2,500 Shares of StockMay 13, 2026 | insidertrades.comWhy Medifast's $15 Cash Per Share Makes It A Strong BuyMay 12, 2026 | seekingalpha.comMedifast: Worth Putting On A WatchlistMay 12, 2026 | seekingalpha.comMedifast (NYSE:MED) Stock Passes Above Two Hundred Day Moving Average - What's Next?May 12, 2026 | americanbankingnews.comMedifast (NYSE:MED) delivers impressive Q1 CY2026May 6, 2026 | msn.comWhy is Medifast stock surging despite weak Q1? $30M cost-cut planMay 5, 2026 | msn.comMedifast Q1 Loss Narrower Than Expected, Revenues Decline Y/YMay 5, 2026 | zacks.comMedifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026May 5, 2026 | seekingalpha.comMedifast, Inc. Q1 2026 Earnings Call SummaryMay 5, 2026 | finance.yahoo.comMedifast Q1 Earnings Call HighlightsMay 4, 2026 | marketbeat.comMedifast Earnings Call: Productivity Rises Amid Sharp DeclineMay 4, 2026 | tipranks.comMedifast, Inc. (MED) Q1 2026 Earnings Call TranscriptMay 4, 2026 | seekingalpha.comMedifast (MED) Reports Q1 Loss, Tops Revenue EstimatesMay 4, 2026 | zacks.comMedifast (NYSE:MED) Issues Q2 2026 Earnings GuidanceMay 4, 2026 | marketbeat.comMedifast (NYSE:MED) Releases FY 2026 Earnings GuidanceMay 4, 2026 | marketbeat.comMedifast (NYSE:MED) Announces Earnings Results, Beats Estimates By $0.36 EPSMay 4, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMED and FRE Company DescriptionsFremont Gold CVE:FREC$0.15 0.00 (0.00%) As of 11/5/2024Fremont Gold Ltd., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral properties in the United States and Canada. The company explores for gold and copper deposit. The company was formerly known as Palisades Ventures Inc. and changed its name to Fremont Gold Ltd. in June 2017. Fremont Gold Ltd. was incorporated in 2007 and is headquartered in Vancouver, Canada.Medifast NYSE:MED$12.60 +0.00 (+0.01%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$12.64 +0.04 (+0.31%) As of 05/21/2026 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
